Screener
Collegium Pharmaceutical, Inc. COLL Segment — Segment Reporting, Other Segment Item, Amount
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:34 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053851
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Medical expenses | 7,899 | 7,832 | 15,047 | 15,865 |
| Technical operations expenses | 165 | 136 | 415 | 234 |
| Stock-based compensation expense | 14,484 | 10,818 | 25,364 | 22,342 |
| Other segment items(1) | 25,480 | 577 | 31,655 | 2,477 |
| Interest expense | 19,519 | 20,463 | 35,381 | 41,253 |
| Interest income | (2,289) | (2,383) | (5,995) | (4,608) |
| Provision for income taxes | 1,519 | 5,042 | 5,763 | 5,747 |
| Net (loss) income | $(15,051) | $11,983 | $(555) | $14,400 |
Item 1. Condensed Consolidated Financial Statements (Unaudited).
FAQ
- What is Collegium Pharmaceutical, Inc.'s segment — segment reporting, other segment item, amount?
- Collegium Pharmaceutical, Inc. (COLL) reported segment — segment reporting, other segment item, amount of $25.48M in Q2 2026.
- How has Collegium Pharmaceutical, Inc.'s segment — segment reporting, other segment item, amount changed year-over-year?
- Collegium Pharmaceutical, Inc.'s segment — segment reporting, other segment item, amount increased by 4315.9% year-over-year, from $577K to $25.48M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s segment — segment reporting, other segment item, amount?
- Over 3 years (2022 to 2025), Collegium Pharmaceutical, Inc.'s segment — segment reporting, other segment item, amount has grown at a -48.0% compound annual growth rate (CAGR), from $31.3M to $4.39M.
- What does segment — segment reporting, other segment item, amount mean?
- Captures miscellaneous or non-recurring items specific to the business segment that do not fall into standard operating expense categories. It provides transparency into unique operational events or adjustments affecting segment-level performance.
Ask your AI about Collegium Pharmaceutical, Inc.'s segment — segment reporting, other segment item, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude